Proopiomelanocortin

Jump to: navigation, search
Proopiomelanocortin
Identifiers
Symbol POMC
Entrez 5443
HUGO 9201
OMIM 176830
RefSeq NM_000939
UniProt P01189
Other data
Locus Chr. 2 p23

WikiDoc Resources for

Proopiomelanocortin

Articles

Most recent articles on Proopiomelanocortin

Most cited articles on Proopiomelanocortin

Review articles on Proopiomelanocortin

Articles on Proopiomelanocortin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Proopiomelanocortin

Images of Proopiomelanocortin

Photos of Proopiomelanocortin

Podcasts & MP3s on Proopiomelanocortin

Videos on Proopiomelanocortin

Evidence Based Medicine

Cochrane Collaboration on Proopiomelanocortin

Bandolier on Proopiomelanocortin

TRIP on Proopiomelanocortin

Clinical Trials

Ongoing Trials on Proopiomelanocortin at Clinical Trials.gov

Trial results on Proopiomelanocortin

Clinical Trials on Proopiomelanocortin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Proopiomelanocortin

NICE Guidance on Proopiomelanocortin

NHS PRODIGY Guidance

FDA on Proopiomelanocortin

CDC on Proopiomelanocortin

Books

Books on Proopiomelanocortin

News

Proopiomelanocortin in the news

Be alerted to news on Proopiomelanocortin

News trends on Proopiomelanocortin

Commentary

Blogs on Proopiomelanocortin

Definitions

Definitions of Proopiomelanocortin

Patient Resources / Community

Patient resources on Proopiomelanocortin

Discussion groups on Proopiomelanocortin

Patient Handouts on Proopiomelanocortin

Directions to Hospitals Treating Proopiomelanocortin

Risk calculators and risk factors for Proopiomelanocortin

Healthcare Provider Resources

Symptoms of Proopiomelanocortin

Causes & Risk Factors for Proopiomelanocortin

Diagnostic studies for Proopiomelanocortin

Treatment of Proopiomelanocortin

Continuing Medical Education (CME)

CME Programs on Proopiomelanocortin

International

Proopiomelanocortin en Espanol

Proopiomelanocortin en Francais

Business

Proopiomelanocortin in the Marketplace

Patents on Proopiomelanocortin

Experimental / Informatics

List of terms related to Proopiomelanocortin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues.

Production

It is synthesised by

Derivatives

The large molecule of POMC is the source of several important biologically active substances. POMC can be cleaved enzymatically into the following peptides:

Although the N-terminal 5 amino acids of beta-endorphin are identical to the sequence of Met-enkephalin, it is not generally thought that beta-endorphin is converted into Met-enkephalin. Instead, Met-enkephalin is produced from its own precursor, proenkephalin.

The production of beta-MSH occurs in humans but not in mice or rats due to the absence of the enzymatic processing site in the rodent POMC.

Functions

Each of these peptides is packaged in large dense-core vesicles that are released from the cells by exocytosis in response to appropriate stimulation.

  • α-MSH produced by neurons in the arcuate nucleus has important roles in the regulation of appetite and sexual behavior, while α-MSH secreted from the intermediate lobe of the pituitary regulates the production of melanin.
  • ACTH is a peptide hormone that regulates the secretion of glucocorticoids from the adrenal cortex.
  • β-endorphin and met-enkephalin are endogenous opioid peptides with widespread actions in the brain.

See also

External links

Cost Effectiveness of Proopiomelanocortin

| group5 = Clinical Trials Involving Proopiomelanocortin | list5 = Ongoing Trials on Proopiomelanocortin at Clinical Trials.govTrial results on ProopiomelanocortinClinical Trials on Proopiomelanocortin at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Proopiomelanocortin | list6 = US National Guidelines Clearinghouse on ProopiomelanocortinNICE Guidance on ProopiomelanocortinNHS PRODIGY GuidanceFDA on ProopiomelanocortinCDC on Proopiomelanocortin


| group7 = Textbook Information on Proopiomelanocortin | list7 = Books and Textbook Information on Proopiomelanocortin


| group8 = Pharmacology Resources on Proopiomelanocortin | list8 = AND (Dose)}} Dosing of ProopiomelanocortinAND (drug interactions)}} Drug interactions with ProopiomelanocortinAND (side effects)}} Side effects of ProopiomelanocortinAND (Allergy)}} Allergic reactions to ProopiomelanocortinAND (overdose)}} Overdose information on ProopiomelanocortinAND (carcinogenicity)}} Carcinogenicity information on ProopiomelanocortinAND (pregnancy)}} Proopiomelanocortin in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Proopiomelanocortin


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Proopiomelanocortin | list9 = AND (pharmacogenomics)}} Genetics of ProopiomelanocortinAND (pharmacogenomics)}} Pharmacogenomics of ProopiomelanocortinAND (proteomics)}} Proteomics of Proopiomelanocortin


| group10 = Newstories on Proopiomelanocortin | list10 = Proopiomelanocortin in the newsBe alerted to news on ProopiomelanocortinNews trends on Proopiomelanocortin</small>


| group11 = Commentary on Proopiomelanocortin | list11 = Blogs on Proopiomelanocortin

| group12 = Patient Resources on Proopiomelanocortin | list12 = Patient resources on ProopiomelanocortinDiscussion groups on ProopiomelanocortinPatient Handouts on ProopiomelanocortinDirections to Hospitals Treating ProopiomelanocortinRisk calculators and risk factors for Proopiomelanocortin


| group13 = Healthcare Provider Resources on Proopiomelanocortin | list13 = Symptoms of ProopiomelanocortinCauses & Risk Factors for ProopiomelanocortinDiagnostic studies for ProopiomelanocortinTreatment of Proopiomelanocortin

| group14 = Continuing Medical Education (CME) Programs on Proopiomelanocortin | list14 = CME Programs on Proopiomelanocortin

| group15 = International Resources on Proopiomelanocortin | list15 = Proopiomelanocortin en EspanolProopiomelanocortin en Francais

| group16 = Business Resources on Proopiomelanocortin | list16 = Proopiomelanocortin in the MarketplacePatents on Proopiomelanocortin

| group17 = Informatics Resources on Proopiomelanocortin | list17 = List of terms related to Proopiomelanocortin


}}

de:Proopiomelanocortin

Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages